FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/08/027181 [Registered on: 17/08/2020] Trial Registered Prospectively
Last Modified On: 12/08/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To evaluate the efficacy of indrayanadi churna with guda in the management of Bahupitta Kamala 
Scientific Title of Study   Randomized controlled clinical trial to evaluate the efficacy of indrayanadi churna with guda in the management of Bahupitta Kamala 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sumant Andhale 
Designation  PG Scholar 
Affiliation  SST Ayurved Mahavidyalaya sangamner 
Address  At Pimplarui post chikhalbeed tq Wadwani Distric Bid maharashtra
SST Ayurved Mahavidyalaya, 2nd floor Kayachikista department Nasik pune road ,opp prasad cafe ,Distric Ahmedanagar ,Sangamner Maharashtra 422605
Bid
MAHARASHTRA
431124
India 
Phone  8767819788  
Fax    
Email  sumantandhale@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr swati Soman  
Designation  Head of department 
Affiliation  SST Ayurved Mahavidyalaya Sangamner 
Address  Soman house,State Bank colony,Ganesh nagar ,Distric Ahmedanagar ,Sangamner Maharashtra 422605
SST Ayurved Mahavidyalaya,2nd floor kayachikista department Nasik pune road ,opp prasad cafe ,Distric Ahmedanagar ,Sangamner Maharashtra 422605
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9421438173  
Fax    
Email  Swati.soman68@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr swati Soman  
Designation  Head of department 
Affiliation  SST Ayurved Mahavidyalaya Sangamner 
Address  Soman house, State bank colony Ganesh nagar ,Distric Ahmedanagar ,Sangamner Maharashtra 422605
SST Ayurved Mahavidyalaya 2nd floor kayachikista department Nasik pune road ,opp prasad cafe ,Distric Ahmedanagar ,Sangamner Maharashtra 422605
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9421438173  
Fax    
Email  Swati.soman68@gmail.com  
 
Source of Monetary or Material Support  
SST Ayurved Mahavidyalaya Nasik pune road ,opp prasad cafe ,Distric Ahmedanagar ,Sangamner Maharashtra 422605 
 
Primary Sponsor  
Name  Dr sumant Andhale 
Address  At Pimplarui Post Chikhalbeed, Tq Wadwani ,Distric Beed, Maharashtra 431124 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sumant Andhale  SST Ayurved Mahavidyalaya sangamner  kayachikista OPD No 2 ground floor and Kayachikista IPD ward 2nd floor SST Ayurved Mahavidyalaya Nasik pune road ,opp prasad cafe ,Distric Ahmedanagar ,Sangamner Maharashtra 422605
Ahmadnagar
MAHARASHTRA 
8767819788

sumantandhale@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BORS committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B199||Unspecified viral hepatitis without hepatic coma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Indrayanadi churna  Indrayanadi churna containing indrayan and shunti with anupan Guda will be administered orally, Dose 1 gm after meal of morning and night ,Duration pf therapy 28 days 
Comparator Agent  Nishottar churna   Nishottar churn with anupan Triphala churna will be administered orally ,Dose 2gm after mealof morning and night, Duration of therapy 28 days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients having sign and symptoms of Bahupitta kamala
Serum bilirubin above 3 mg/dl 
 
ExclusionCriteria 
Details  Known cases of Ruddhapatha kamala, kumbhakamala, Halimaka
ï‚· Serum Bilirubin more than 12mg /dl 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Indrayanadi churna with Guda is effective in the management of Bahupitta kamala  Indrayanadi churna with Guda is effective in the management of Bahupitta kamala in 4 week 
 
Secondary Outcome  
Outcome  TimePoints 
Nishottar churna with Triphala kwatha does not have or has less effective in the management of bahupitta kamala in 4 week  Nishottar churna with Triphala kwatha has no or less singnificant improvement in sign and symptoms of bahupitta kamala

Outcome will be assessed daily from 0 day to day 28 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/08/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Hypothesis ÷ Indrayanadi churna with guda is effective in the management of Bahupitta kamala

Trial group Drugs ÷ Indrayanadi churna

Contents of Trial Drugs ÷ Indrayana ,Shunthi

Method of preparation÷ Indrayana and Shunthi taken in equal quantity and pounded seperately in fine powder and sieved then mixed together and mixture will be filtered by cotton cloth

Control group Drugs÷ Nishottar churna

Results ÷ Will be assessed maily on the basis of relief in sign and symptoms and level of serum bilirubin, patient will be taken in clinical trial from day  0 to day 28
 
Close